Isolated Subsegmental Pulmonary Embolism
Isolated Subsegmental Pulmonary Embolism is a type of pulmonary embolism where a blood clot blocks a small branch of the pulmonary artery, often leading to symptoms like shortness of breath and chest pain.
Pulmonary Embolism: Surveillance vs. Anticoagulation
We are studying whether monitoring without blood thinners is as safe and effective as using them for low-risk patients with isolated subsegmental pulmonary embolism. This trial will also assess side effects and quality of life for participants.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have any active cancer that has been treated in the last 6 months?
- Are you currently pregnant or breastfeeding?
- Are you taking any blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had a major medical event like hospitalization for more than 72 hours in the past month?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Aban
Agublon
Assubex
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Cliniques Universitaires Saint-Luc
Emergency Department
Sint-Stevens-Woluwe, Belgium
Centre hospitalier universitaire de Liege
Emergency Department
Tilff, Belgium
CHU Gabriel-Montpied
Service des urgences
Beaumont, France
Sponsor: Insel Gruppe AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.